NCT05658302 Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst
| NCT ID | NCT05658302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-03-28 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2023-03-28 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will help us better understand how the brain works in people with Parkinson's disease (PD). PD is a brain disease that gets worse over time, and affects over 10 million people world-wide. A common treatment for PD is Deep Brain Stimulation (DBS). To improve DBS therapy for PD, we need a deeper understanding of how the different parts of the brain work together in PD, and how this relates to movement and thinking problems that people with PD experience. We may be able to use the results of this study to improve DBS treatments in the future.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of idiopathic PD * Surgery at UMN to implant DBS system with directional lead(s) and multiple independent current control IPG is planned as part of routine clinical care * At least 21 years old Exclusion Criteria: * Other significant neurological disorder * History of dementia * Patients with post-operative complications or adverse effects (e.g. ON stimulation dystonias) that affect patient safety or confound the experiment will be excluded from further study * Pregnant women * Known radiation exposure within the last year that is determined to be unsafe when compounded with the expected radiation dose from intraoperative fluoroscopy to place ECoG strip
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05658302 clinical trial?
This trial is open to female participants only, aged 21 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05658302 currently recruiting?
Yes, NCT05658302 is actively recruiting participants. Contact the research team at weath210@umn.edu for enrollment information.
Where is the NCT05658302 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT05658302 clinical trial?
NCT05658302 is sponsored by University of Minnesota. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.